MARKET

AROAF

AROAF

Aroa Biosurgery Ltd
OTCPK
0.500
NaN%
Opening 09:30 02/13 EST
OPEN
--
PREV CLOSE
0.500
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.500
52 WEEK LOW
0.500
MARKET CAP
172.74M
P/E (TTM)
-161.2903
1D
5D
1M
3M
1Y
5Y
1D
No Data
About AROAF
Aroa Biosurgery Limited is a soft-tissue regeneration company. It develops, manufactures, sells, and distributes medical and surgical products to improve healing in complex wounds and soft tissue reconstruction. Its products are developed from the AROA extracellular matrix (ECM) technology platform, an extracellular matrix biomaterial derived from the ovine forestomach. AROA ECM is an ECM biomaterial containing a rich and complex mix of biological molecules that serve as the building blocks for a range of soft tissue repair products. Its products include Endoform, Myriad Matrix, Myriad Morcells, Myriad Morcells Fine, Symphony, and Reinforced Bioscaffolds. Endoform products support all phases of wound healing and are appropriate for use early in wound management to restore protease balance and advance healing to the proliferative phase. Myriad Matrix is an engineered ECM designed for soft tissue repair, reinforcement, and complex wounds.

Webull offers Aroa Biosurgery Ltd stock information, including OTCPK: AROAF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AROAF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AROAF stock methods without spending real money on the virtual paper trading platform.